Project Grant R03HD106185

Award Date 6/9/22
Completion Date 5/31/24
Dollars Obligated $216K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Uganda
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $335,559 to the University of North Carolina at Chapel Hill to conduct a pilot randomized controlled trial on the feasibility, acceptability, and preliminary effectiveness of a Focal Mass Drug Administration (FMDA) program for household members of pregnant women to protect against malaria in pregnancy (MIP). The key...
This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $239,366 to The Leland Stanford Junior University to evaluate the causal effects of anti-malarial chemoprevention in pregnancy and childhood on growth outcomes. The study aims to (1) assess the impact of intermittent preventative treatments in pregnancy (IPTp) and childhood (IPTc) on child growth, and (2) investigate...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $186,319 to The Regents of the University of California, San Francisco (UCSF) to adapt and test an intervention to reduce HIV-related stigma among pregnant and postpartum women in sub-Saharan Africa. The key activities include: 1) Describing the stigma experiences and mental health impacts of women living with HIV during...
This $196,881 Project Grant was awarded by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) to adapt and pilot test an intervention to reduce alcohol use and improve HIV care outcomes among men living with HIV who have serodiscordant pregnant partners in Uganda. The overarching goal is to adapt the KISOBOKA intervention, which utilizes motivational interviewing and behavioral economics techniques, for use with this target...
This federal Project Grant award of $1,365,212 from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) aims to optimize and test a peer-led dynamic choice HIV prevention intervention to increase coverage of biomedical prevention products among women at elevated HIV risk in southwestern Uganda. The project will refine the existing Search Dynamic Choice HIV Prevention (DCP) intervention to further engage women working in venues where transactional sex is...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a longitudinal cohort study to examine the impact of early childhood malaria prevention interventions on malaria risk in school-age children in Ghana. The study, titled "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)", will evaluate the epidemiological and...
This Project Grant award of $590,710, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to strengthen informed consent for authentic participation in perinatal HIV research. The project aims to evaluate the use of a visual informed consent form developed to improve comprehension and decision-making among low-literacy populations affected by HIV in South Africa....
This Project Grant award of $595,552 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will develop and test a two-way SMS platform to prevent and treat wasting among HIV-infected and HIV-exposed uninfected children. The project will create a Maternally Administered Malnutrition Monitoring System (MAMMS) combined with Infant and Young Child Education (IYCF) delivered via SMS. After...
This Project Grant award from the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training) will provide $108,916 to Kamuzu University of Health Sciences in Malawi to characterize the pharmacokinetic and safety profiles of the antimalarial drugs artemether-lumefantrine plus amodiaquine (ALAQ) in two key target populations: children with severe acute malnutrition and adults living with HIV on dolutegravir-based antiretroviral...

A NOVEL VIDEO-BASED INTERVENTION TO ENHANCE OPTIMAL UPTAKE OF MALARIA PREVENTIVE THERAPY: A PILOT STUDY OF A HEALTH EDUCATIONAL APPROACH TO MALARIA PREVENTION DURING PREGNANCY - PROJECT SUMMARY: MALARIA IN PREGNANCY REMAINS A MAJOR PUBLIC HEALTH CONCERN THAT IS ASSOCIATED WITH MATERNAL AND FETAL ADVERSE EVENTS AND IS THE LEADING CAUSE OF PREVENTABLE MATERNAL DEATHS IN SUB-SAHARAN AFRICA. DESPITE THE PROVEN EFFICACY OF SULPHADOXINE-PYRIMETHAMINE (INTERMITTENT PROPHYLAXIS TREATMENT OF MALARIA_ IPTP_SP) AND COTRIMOXAZOLE AS PROPHYLAXIS TREATMENT OF MALARIA IN HIV NEGATIVE AND HIV POSITIVE PREGNANT WOMEN RESPECTIVELY, ADHERENCE TO THESE MEDICATIONS REMAINS UNACCEPTABLE IN UGANDA ESPECIALLY IN KAMPALA. SUB-OPTIMAL ADHERENCE TO MALARIA PREVENTIVE THERAPY IS REPORTED TO BE DUE TO LACK OF EDUCATION OR IGNORANCE ABOUT THESE INTERVENTIONS AMONG PREGNANT WOMEN, AND THE LACK OF EXPOSURE TO MALARIA PREVENTION MESSAGES TO STIMULATE BEHAVIORAL CHANGE. ADDITIONALLY, DUE TO OVERPOPULATION IN KAMPALA AND THE PERSISTENT SHORTAGE OF HEALTH WORKERS LIKE IN MANY OTHER LOW RESOURCE SETTINGS, HEALTH WORKERS OFTEN DON'T HAVE ADEQUATE TIME TO SUFFICIENTLY EDUCATE PREGNANT WOMEN ABOUT ALL ANTENATAL CARE PROCEDURES INCLUDING THE IPTP-SP DOSING SCHEDULE FOR HIV NEGATIVE PREGNANT WOMEN AND RE INITIATION TO COTRIMOXAZOLE FOR HIV POSITIVE PREGNANT WOMEN. TO ADDRESS THIS CRITICAL KNOWLEDGE GAP ON ADEQUATE MALARIA PREVENTIVE THERAPY UTILIZATION AMONG PREGNANT WOMEN, WE PROPOSE A COMBINED IMPLEMENTATION AND DISSEMINATION INTERVENTIONAL APPROACH. THIS WILL PRIMARILY INVOLVE THE DEVELOPMENT OF THE INTERVENTION NAMED "PREVENT" (PREVENTION OF MALARIA IN PREGNANCY USING VIDEO-BASED EDUCATION TO ENHANCE OPTIMAL MALARIA PREVENTIVE THERAPY KNOWLEDGE AND UPTAKE). IN THIS R03, WE WILL DEVELOP, TAILOR, AND REFINE THE VIDEO TO ADDRESS MALARIA PREVENTIVE THERAPY KNOWLEDGE DEFICITS IN A CLIENT-CENTERED MANNER. THE PREVENT INTERVENTION WILL INVOLVE A 10 MIN VIDEO TO EDUCATE PREGNANT WOMEN ABOUT CURRENT IPTP-SP AND COTRIMOXAZOLE RECOMMENDATIONS DURING ANC FOLLOWED BY A 5 MIN QUESTION AND ANSWER SESSION WITH A HEALTH WORKER. WE WILL QUALITATIVELY ASSESS THE PREVENT INTERVENTION FOR FEASIBILITY, ACCEPTABILITY, AND APPROPRIATENESS USING A PILOT STUDY IN AN URBAN PUBLIC HEALTH FACILITY. THE OBTAINED DATA WILL BE USED TO PREPARE FOR AN R21 GRANT IN WHICH WE WILL RIGOROUSLY EVALUATE THE EFFECTIVENESS OF THE INTERVENTION IN INCREASING OPTIMAL IPTP-SP AND COTRIMOXAZOLE UPTAKE. ULTIMATELY, THIS AND PROGRESSIVE STUDIES WILL RESULT IN THE DEVELOPMENT OF A COST-EFFECTIVE, EVIDENCE-BASED, AND SCALABLE INTERVENTION THAT WILL EVENTUALLY REDUCE MALARIA- RELATED MATERNAL AND NEONATAL ADVERSE OUTCOMES.

Posted 6/9/22, 12:00 AM